Qi‐Xiang Li

2.8k total citations
73 papers, 1.8k citations indexed

About

Qi‐Xiang Li is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Qi‐Xiang Li has authored 73 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 23 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Qi‐Xiang Li's work include RNA Interference and Gene Delivery (9 papers), Cancer Genomics and Diagnostics (7 papers) and Advanced biosensing and bioanalysis techniques (7 papers). Qi‐Xiang Li is often cited by papers focused on RNA Interference and Gene Delivery (9 papers), Cancer Genomics and Diagnostics (7 papers) and Advanced biosensing and bioanalysis techniques (7 papers). Qi‐Xiang Li collaborates with scholars based in China, United States and Switzerland. Qi‐Xiang Li's co-authors include Flossie Wong‐Staal, Ke Ning, Dehua Yu, Sheng Guo, Mirta Grifman, Bernd Meyhack, Xiaoyu An, Xuesong Ouyang, Jean‐Pierre Wery and Jon E. Chatterton and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Qi‐Xiang Li

70 papers receiving 1.7k citations

Peers

Countries citing papers authored by Qi‐Xiang Li

Since Specialization

Citations

This map shows the geographic impact of Qi‐Xiang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi‐Xiang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi‐Xiang Li more than expected).

Fields of papers citing papers by Qi‐Xiang Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi‐Xiang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi‐Xiang Li. The network helps show where Qi‐Xiang Li may publish in the future.

Co-authorship network of co-authors of Qi‐Xiang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Qi‐Xiang Li. A scholar is included among the top collaborators of Qi‐Xiang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi‐Xiang Li. Qi‐Xiang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	NONO interacts with nuclear PKM2 and directs histone H3 phosphorylation to promote triple-negative breast cancer metastasis 2025 ·Journal of Experimental & Clinical Cancer Research ·Qi‐Xiang Li, (unknown), Pengpeng Zhao, (unknown), Yi Zou, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yuzhong Chen, (unknown), Bing Chen, Ling‐Dong Kong, Ke Zen, David C.S. Huang, Zhiwei Jiang, Quan Zhao	4
2	Exploring the Potential Mechanisms of Guanxinshutong Capsules in Treating Pathological Cardiac Hypertrophy based on Network Pharmacology, Computer-Aided Drug Design, and Animal Experiments 2024 ·ACS Omega ·Yuanfeng Liu, Qi‐Xiang Li, Chongyu Shao, (unknown), Huifen Zhou, Yan Guo, (unknown), (unknown), Jiehong Yang, Haitong Wan	5
3	HX009, a novel BsAb dual targeting PD1 x CD47, demonstrates potent anti-lymphoma activity in preclinical models 2023 ·Scientific Reports ·(unknown), Faming Zhang, Jingjing Wang, (unknown), Xiaoyu An, Xiaolong Tu, Cen Chen, Yueying Wang, Binchen Mao, Sheng Guo, (unknown), (unknown), Ruilin Sun, Lei Zhang, Owen A. O’Connor, Qi‐Xiang Li	15
4	Tumor Purity in Preclinical Mouse Tumor Models 2022 ·Cancer Research Communications ·Wubin Qian, Xiaobo Chen, (unknown), Likun Zhang, Jingjing Wang, (unknown), Qi‐Xiang Li, Sheng Guo	6
5	Different syngeneic tumors show distinctive intrinsic tumor-immunity and mechanisms of actions (MOA) of anti-PD-1 treatment 2022 ·Scientific Reports ·Ying Jin, Xiaoyu An, Binchen Mao, Ruilin Sun, Rajendra Kumari, Xiaobo Chen, Yongli Shan, (unknown), Ling Xu, Jan Muntel, (unknown), Roland Bruderer, Lukas Reiter, Sheng Guo, Demin Zhou, Qi‐Xiang Li, Xuesong Ouyang	40
6	Preclinical pharmacology modeling of chimeric antigen receptor T therapies 2021 ·Current Opinion in Pharmacology ·Rajendra Kumari, Xuesong Ouyang, Jingjing Wang, Xiaoxi Xu, Meiling Zheng, Xiaoyu An, Qi‐Xiang Li	17
7	The design, analysis and application of mouse clinical trials in oncology drug development 2019 ·BMC Cancer ·Sheng Guo, Xiaoqian Jiang, Binchen Mao, Qi‐Xiang Li	39
8	[Monocarboxylate transporter 1 enhances the sensitivity of breast cancer cells to 3-bromopyruvate in vitro]. 2017 ·PubMed ·Qi‐Xiang Li, Pei Zhang, Fang Liu, Xianzhi Wang, (unknown), (unknown), Chenchen Jiang, Hailun Zheng, Hao Liu	4
9	Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines 2016 ·Cancer Research ·Sheng Guo, Wubin Qian, Jie Cai, (unknown), Jean‐Pierre Wery, Qi‐Xiang Li	38
10	A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy 2013 ·Scientific Reports ·Lianhai Zhang, Jie Yang, Jie Cai, Xiaoming Song, (unknown), (unknown), Dawei Chen, Mengmeng Yang, Jean‐Pierre Wery, Shuangxi Li, Aiwen Wu, Ziyu Li, Zhongwu Li, Yiqiang Liu, (unknown), Qi‐Xiang Li, Jiafu Ji	70
11	Overcoming erlotinib resistance with tailored treatment regimen in patient‐derived xenografts from naïve Asian NSCLC patients 2012 ·International Journal of Cancer ·Mengmeng Yang, Baoen Shan, (unknown), (unknown), Xiaoming Song, Jie Cai, (unknown), Likun Zhang, Zhenjian Du, Junjie Lu, Taiping Chen, Jean‐Pierre Wery, (unknown), Qi‐Xiang Li	44
12	Pharmacological Characterization of Chemically Synthesized Monomeric phi29 pRNA Nanoparticles for Systemic Delivery 2011 ·Molecular Therapy ·(unknown), Songchuan Guo, Limin Zhang, Sai Murali Krishna Pulukuri, (unknown), (unknown), (unknown), Peixuan Guo, Qi‐Xiang Li	94
13	Orphan G protein–coupled receptor GPR56 plays a role in cell transformation and tumorigenesis involving the cell adhesion pathway 2007 ·Molecular Cancer Therapeutics ·Ke Ning, Roshni Sundaram, Guohong Liu, John Chionis, Wufang Fan, (unknown), Tarif Awad, Mirta Grifman, Dehua Yu, Flossie Wong‐Staal, Qi‐Xiang Li	60
14	Isoginkgetin enhances adiponectin secretion from differentiated adiposarcoma cells via a novel pathway involving AMP-activated protein kinase 2007 ·Journal of Endocrinology ·Guohong Liu, Mirta Grifman, James E. Macdonald, Peter Möller, Flossie Wong‐Staal, Qi‐Xiang Li	33
15	Biochemical characterization of genetic mutations of GPR56 in patients with bilateral frontoparietal polymicrogyria (BFPP) 2007 ·Biochemical and Biophysical Research Communications ·Ke Ning, Hongwen Ma, Gundo Diedrich, John Chionis, Guohong Liu, Dehua Yu, Flossie Wong‐Staal, Qi‐Xiang Li	25
16	A more efficient RNAi inducible system for tight regulation of gene expression in mammalian cells and xenograft animals 2007 ·RNA ·Jing Zhang, Cuiying Wang, Ke Ning, Josh Bliesath, John Chionis, (unknown), Qi‐Xiang Li, Jon E. Chatterton, Flossie Wong‐Staal, Demin Zhou	21
17	PHTS, a novel putative tumor suppressor, is involved in the transformation reversion of HeLaHF cells independently of the p53 pathway 2006 ·Experimental Cell Research ·Dehua Yu, Wufang Fan, Guohong Liu, (unknown), Jon E. Chatterton, (unknown), Ke Ning, Bernd Meyhack, (unknown), Arndt Brachat, Flossie Wong‐Staal, Qi‐Xiang Li	14
18	A novel RNAi library based on partially randomized consensus sequences of nuclear receptors: Identifying the receptors involved in amyloid β degradation 2006 ·Genomics ·Jianping Yang, Wufang Fan, (unknown), Jon E. Chatterton, Joshua Bliesath, Guohong Liu, Ke Ning, Cuiying Wang, Kristina Rhoades, Flossie Wong‐Staal, Qi‐Xiang Li	10
19	A 96-Well Surrogate Survival Assay Coupled with a Special Short Interfering RNA Vector for Assessing Cancer Gene Targets with Enhanced Signal/Noise Ratio and Its Utility in HTS for Cancer Therapeutic Targets 2005 ·Assay and Drug Development Technologies ·Dehua Yu, Jon E. Chatterton, Joshua Bliesath, Roshni Sundaram, Ke Ning, (unknown), Bernd Meyhack, Flossie Wong‐Staal, Qi‐Xiang Li	12
20	Orphan G-protein coupled receptor GPCR-X as a novel cancer drug target: validation and mechanistic studies 2005 ·Cancer Research ·(unknown), Roshni Sundaram, Wufang Fan, (unknown), Dehua Yu, John Chionis, Demin Zhou, Gisela Claassen, (unknown), Mirta Grifman, Bernd Meyhack, Arndt Brachat, Tarif Awad, (unknown), (unknown), Flossie Wong‐Staal, Qi‐Xiang Li	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact